1. Bassett AS, McDonald-McGinn DM, Devriendt K, Digilio MC, Goldenberg P, Habel A, Marino B, Oskarsdottir S, Philip N, Sullivan K, Swillen A, Vorstman J, International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332-9.e1. https://doi.org/10.1016/j.jpeds.2011.02.039. Epub 2011 May 12. PMID: 21570089; PMCID: PMC3197829.
2. Bawle EV. DiGeorge Syndrome. Medscape. Jul 17, 2018. URL: https://emedicine.medscape.com/article/886526-overview
3. Bennett NM, Pilishvili T, Whitney CG, Moore M, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2013;62(25):521–4.
4. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62(25):521–4. PMID: 23803961; PMCID: PMC4604951
5. Crawford N, McGuire R, Jones P. Asplenia/Hyposplenia Guidelines. Royal Children’s Hospital June 2014. URL: https://mvec.mcri.edu.au/wp-content/uploads/2014/06/ASPLENIA-Guideline-June-2014-UPDATE-.pdf